AccessibilityHelp

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Jeffrey Little

XMFWordman5150

Jeff brought his foolish love for writing and investing to TMF in 2021 after spending most of his career in Marketing Operations. He has been investing for over 30 years, with varied coverage of technology, industrials, cannabis, healthcare, and consumer goods.

Recent Articles by Jeffrey Little

diabetes patient using smartphone to monitor glucose levels

Sep 12, 2022 by Jeffrey Little

Your Portfolio Could Be Missing This Stock With Monster Potential

When a leading healthcare technology stock falls during a bear market it means one thing -- opportunity

person smiling and standing in a field of marijuana plants

Sep 10, 2022 by Jeffrey Little

Wall Street Thinks This Growth Stock Can Gain 131% in 2023

There's a lot to like about Cresco Labs, but its debt still lurks in the shadows.

a family all smiles taking a selfie with a wind turbine in background

Sep 7, 2022 by Jeffrey Little

2 Stocks to Grow and Renew Your Portfolio

It looks like blue skies ahead for these very different growth stocks.

Pharmacist physician aiding a customer

Sep 6, 2022 by Jeffrey Little

Could CVS Maintain Its Momentum in a Post-Pandemic World?

Driving its way into being a full-service healthcare provider will come with challenges but also the potential for reward.

person holding a bowl of marijuana cookies over a table full of marijuana products

Sep 2, 2022 by Jeffrey Little

1 Dynamic Growth Stock for September

September is historically the worst month of the year for the S&P 500. Maybe it's time to think bigger by going smaller.

a young couple holding hands and smiling while speaking with a doctor

Sep 1, 2022 by Jeffrey Little

This Growth Stock Could Provide Big Long-Term Gains

A fertility services company aims to help people succeed in starting families.

person at laptop holding hands together as if praying

Aug 16, 2022 by Jeffrey Little

This Growth Stock Has Soared Over 200% Year to Date -- Is It a Buy?

More than two years into the pandemic, hospitalized patients with severe cases may get a game-changing treatment.

two people looking at documentation as one of them is yawning

Aug 13, 2022 by Jeffrey Little

These 2 "Boring" Stocks Are Nothing to Sleep On

Sometimes getting the biggest returns means broadening your view -- learn to ignore the "boring" factor.

person inspecting marijuana sample in a field of plants

Aug 12, 2022 by Jeffrey Little

This Company Is Poised for Growth in New Markets

As more states adopt recreational-use marijuana laws, federal legalization may not matter to investors.

Three lab technicians celebrating with high-fives and fist pumps

Jul 22, 2022 by Jeffrey Little

2 Pharma Giants With Momentum That Could Carry Through 2030

An obese population could drive competition toward a valuable market.

concerned patient watches cautiously as medical personnel prepares vaccine injection

Jul 22, 2022 by Jeffrey Little

Is This Vaccine Stock a Buy After Big News?

Two years after the onset of COVID-19 in the U.S., a new vaccine is coming to market -- who will it help?

Three biotech personnel in a lab reviewing data on laptop

Jul 19, 2022 by Jeffrey Little

What Monkeypox Could Mean for These 2 Stocks?

Vaccine companies saw stock prices spike during the COVID pandemic. The same could happen amid a new outbreak.

happy trader investing growth profit buy stock celebrate (1)

Jul 12, 2022 by Jeffrey Little

When the Market Recovers, You'll Want to Own These 2 Healthcare ETFs

Diseases evolve, accidents happen, the overall population is aging -- and the demand for treatment, services, and insurance is growing.

Pharma Image_Person waking and smiling from well rested sleep

Jul 8, 2022 by Jeffrey Little

Investors Are Paying Attention to This Pharma That Is Gaining Speed

Can turning one product into a portfolio of products result in revenue magic?

biotech engineers studying samples in lab

Jul 1, 2022 by Jeffrey Little

Amgen's Beating the Market -- Here's Why It's a Buy Now

A blockbuster could be on the way next year -- but if you wait that long to invest, could it be too late?

person laying in bed checking glucose levels with smartphone

Jun 27, 2022 by Jeffrey Little

DexCom's Stock Split Is Complete: Is It Time to Buy?

Many people will keep up their spending on treating chronic conditions, regardless of economic pressures.

investor comparing Wall Street data on laptop vs newspaper

Jun 26, 2022 by Jeffrey Little

Better Buy: Dividend Aristocrats vs. Beaten-Down Tech Stocks

What's right for you depends on your investment strategy.

medical professional looking at hand of patient

Jun 22, 2022 by Jeffrey Little

Could 2023 Be a Breakout Year for This Pharma Stock?

A pending FDA review and promising clinical trial data brings blockbuster potential.

Person inspecting cannabis plant

Jun 20, 2022 by Jeffrey Little

2 Cannabis Growth Stocks You Can Get for Under $15

The real question is, do you want any cannabis stocks right now, regardless of price?

Three people sitting on floor showing hands while painting room

Jun 14, 2022 by Jeffrey Little

Want $4,000 in Passive Income? Invest $10,000 in These Dividend Stocks Now

Here's how to reap big rewards through minimal involvement by showing a bit of patience.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services